America’s superpower has always been its optimism, and an optimistic nation invests in the future. In 1960, the U.S. was the largest spender on R&D, accounting for 69% of global spending. That money ensured the U.S. was a global leader in science and technology, providing us with weather satellites, GPS, the internet, drones, and most recently, messenger-RNA vaccines. Such vaccines were unproven until the U.S. government granted Moderna $25 million in 2013. Almost a decade and a half-billion doses later, it’s safe to say the investment paid off. The U.S. is spending more than ever on R&D, but it now accounts for only 30% of global investment, as other nations recognize the competitive advantages good research brings.